Podcasts about Retinal

This episode we get into a new JAMA Ophthalmology study takes a hard look at pickleball-related eye injuries, and the numbers are… not great. Retinal detachments, hyphemas, orbital fractures, and even open globes are showing up more and more, especially as the sport explodes in popularity among older adults. I break down exactly how these injuries happen, which ones are true emergencies, and why I am once again begging you, politely, but firmly, to wear eye protection while playing pickleball Takeaways: Why pickleball-related eye injuries have surged dramatically in the last few years and why 2024 alone accounted for a huge chunk of them. How a single blunt hit from a pickleball can lead to retinal tears, detachments, or bleeding inside the eye. The most common orbital fracture caused by blunt eye trauma and why age actually changes how dangerous it is. When blood in the eye (hyphema) turns from “watch and wait” into a full-on pants-on emergency. The simplest, cheapest way to avoid becoming an ophthalmology case study: wear safety glasses, especially if your reaction time isn't what it used to be. To Get Tickets to Wife & Death: You can visit Glaucomflecken.com/live  We want to hear YOUR stories (and medical puns)! Shoot us an email and say hi! knockknockhi@human-content.com Can't get enough of us? Shucks. You can support the show on Patreon for early episode access, exclusive bonus shows, livestream hangouts, and much more! –⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ http://www.patreon.com/glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Also, be sure to check out the newsletter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://glaucomflecken.com/glauc-to-me/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you are interested in buying a book from one of our guests, check them all out here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.amazon.com/shop/dr.glaucomflecken⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ If you want more information on models I use: Anatomy Warehouse provides for the best, crafting custom anatomical products, medical simulation kits and presentation models that create a lasting educational impact.  For more information go to Anatomy Warehouse DOT com. Link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anatomywarehouse.com/?aff=14⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Plus for 15% off use code: Glaucomflecken15 -- A friendly reminder from the G's and Tarsus: If you want to learn more about Demodex Blepharitis, making an appointment with your eye doctor for an eyelid exam can help you know for sure. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://www.EyelidCheck.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ for more information.  Go to Cozy Earth now for a Buy One Get One Free Pajama Offer from 1/25-2/8! Yes, go to cozyearth.com they are doing a BOGO pajama promo. Just use my Code: KNOCKKNOCKBOGO Produced by⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Human Content⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

On today's episode of Kelsey Unpacked, we're talking Skincare in the Air, aka my fun travel tradition with my daughter. If we're on an early morning flight, we pull out our toiletry bag and do our skincare right there in our seats.I'm sharing the tools and products that are actually making a difference for my skin in my 40s, plus my must-haves that make it into my toiletry bag. Also sharing the few things I genuinely can't live without.Buy Me A Coffee: https://buymeacoffee.com/kelseygravesFollow me on Instagram: https://www.instagram.com/kelsey_gravesFollow me on TikTok: https://www.tiktok.com/@mskelseygravesJoin us in the Trip Tales Podcast Community Facebook Group: https://www.facebook.com/groups/1323687329158879Mentioned in this episode:- SHOP skincare products on my ShopMy page: https://shopmy.us/collections/public/3657421- Megelin LED Red Light Therapy Face Mask- Medicube Kojic Acid Tumeric Glycolic Acid Pads- Therabody Theraface Depuffing Wand- Maskiss 24K Gold Eye Masks- Cetaphil Gentle Face Cleanser- La Roche-Posay Thermal Water Spray- Tule 'Spresso Energizing Eye Balm- Uncommon Beauty Glutathione Serum- Pacifica Glow Baby Serum- Youth the the People: Triple Peptide Hyaluronic Acid & Retinal and Niacinamide- Olay Pro Advanced Regenerist- La Roche-Posay Tinted Mineral Sunscreen- Hydrafacial- Dysport

Milestone brings hope to patients with rare inherited retinal disease

Dr. Natalia Vergara is an Assistant Professor of Ophthalmology at the Sue Anschutz-Rodgers Eye Center, University of Colorado School of Medicine on the Anschutz Medical Campus. Natalia uses stem cells to understand how the retina forms during development and how it degenerates during disease with the goal of developing therapies to help patients who suffer from vision loss. For her research, Natalia uses a type of stem cells called induced pluripotent stem cells which can be reprogrammed so they can form any type of cell in the body. With these cells, they can make human retina tissue using any individual's cells in a petri dish in the lab to better understand diseases, test treatments, and potentially prepare retinas for transplant. In her free time, Natalia loves hanging out, cooking, and enjoying food with friends and family, including her husband and two young kids. Natalia is also an avid traveler, and she delights in the thrill of discovery that comes along with exploring new places. Natalia received her B.S. in biochemistry from the National University of the Litoral in Argentina. She worked as an instructor and research intern at the National University of Entre Ríos for about three years before beginning graduate school. Natalia was awarded her PhD in retinal regenerative biology from Miami University in Ohio. Afterwards, she conducted postdoctoral research at the Wilmer Eye Institute of Johns Hopkins School of Medicine. She served as a Research Associate Faculty member at Johns Hopkins School of Medicine for about two years before joining the faculty at the University of Colorado. Natalia has received awards for research and for mentoring, including the Ruben Adler Research Award from the Wilmer Eye Institute at Johns Hopkins University School of Medicine in 2012, and she was selected as an Emerging Vision Scientist to participate in the Third Annual EVS day on Capitol Hill by the National Alliance for Eye and Vision Research in 2017. In our interview, Natalia tells us more about her life and science.

In this episode, we explore tutka, a promising neuroprotective nutrient that may help preserve photoreceptors and stabilize visual signaling across several retinal diseases. We share how it works, where research stands, practical dosing, and simple ways to reduce side effects.• why photoreceptors fail under oxidative stress and inflammation• where tutka shows promise across diabetic retinopathy, RP, glaucoma, and detachment recovery• how tutka works to reduce cell death and stabilize signaling• practical dosing ranges, timing with meals, and titration tips• safety notes, common digestive side effects, and upper limits• emerging sustained-release implants and what is available now• lifestyle and nutrition steps that complement tutka for eye healthFor more information, visit naturaleycare.com and doctorgrossman2020.comOur email address is info@naturaleyecare.com. If you have any questions, call us 845 475 4158

Host Dr. Jay Sridhar welcomes Drs. Michael Ip and Sophie Bakri to discuss the challenges in caring for patients with macular edema secondary to retinal vein occlusion (RVO). The panel reviews the current approach to treatment using anti-VEGF agents and factors that may suggest a need for more intensive, long-term treatment. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Akshay Thomas and Sarwar Zahid join to discuss the January 2026 edition of Retinal Physician, including OCT angiography, wearables for retinal health, heads-up display for retinal surgery, and endogenous fungal endophthalmitis.

We discuss promising Phase 2 results from Nanoscope regarding the use of optogenetics for treatment of retinal degenerations with Allen Ho, MD, Professor of Ophthalmology, Wills Eye Hospital.

Lorena Penas de " ACTUAL COMUNICACIÓN - amodiño", empresa que se adica á xestión da comunicación dixital. Esta sección está centrada na comunicación dixital, nas redes sociais e nas ferramentas que necesitamos hoxe para expresarnos con creatividade e eficacia. Nesta sección propoñemos reflexións, consellos e estratexias para estar ao tanto das tendencias, optimizar a presenza dixital e resolver aquelas cuestións que xurden ao comunicar nas plataformas dixitais. Hoxe: Isto foi o máis buscado en Google en España e o mundo en 2025 "A listaxe Top Tendencias recopila aquelas consultas que experimentaron un maior repunte de tráfico durante un período de tempo prolongado durante este ano en comparación co anterior". "A clasificación de busquedas é realmente diverso, deixando patente tanto a relevancia do seguimento en tempo real de fenómenos de actualidade, meteorolóxicos ou que afectan a contorna ambiental, culturais ou de entretemento e mesmo científicos". "Debido ás novas funcións de IA en Google (AI Overviews e AI Mode) nosa forma de buscar cambiou e volveuse máis conversacional. É por iso que este 2025 moitos tops baséanse en preguntas do estilo “como…”, “que é mellor…” ou “que significa…". Google acaba de presentar o seu resumo de procuras 2025, unha recopilación das tendencias que marcaron o ano, converténdose no máis buscado na web. Os datos de España reflicten unha gran actividade informativa, destacando o interese por fenómenos globais así como por solucións creativas para o día a día. Así mesmo, debido ás novas funcións de IA en Google (AI Overviews e AI Mode) nosa forma de buscar cambiou e volveuse máis conversacional. É por iso que este 2025 moitos tops baséanse en preguntas do estilo “como…”, “que é mellor…” ou “que significa…”. O máis buscado en Google en España ➡️Top tendencias A listaxe Top Tendencias recopila aquelas consultas que experimentaron un maior repunte de tráfico durante un período de tempo prolongado durante este ano en comparación co anterior. É dicir, son procuras que rexistraron grandes picos de interese en 2025, sendo temas exclusivos deste ano. A clasificación resultante é realmente diverso, deixando patente tanto a relevancia do seguimento en tempo real de fenómenos de actualidade (Apagamento España, Novo Papa ou Flotilla Gaza), meteorolóxicos ou que afectan a contorna ambiental (Alerta choivas ou Incendios España), culturais ou de entretemento (Lalachus, A Revolta, Premio Planeta 2025 ou Labubu) e mesmo científicos (Migración da bolboreta monarca). Películas e series 1. Anora 2. Sirat 3. La infiltrada 4. Nosferatu 5. Weapons 6. The Brutalist 7. El 47 8. Superman 9. Emilia Pérez 10. Adolescencia ❓Quen é… 1. O novo Papa 2. Andy y quién es Lucas 3. Lalachus 4. Topuria 5. Salva Reina 6. Abby 7. Karla Sofia Gascón 8. Montoya 9. Rosalía 10. Alcaraz ✅Cómo… 1. Hacer fotos con IA 2. Hacer caca en el trabajo 3. Quitar maquillaje de la almohada 4. Hacer fuego con dos palos 5. Hacer crepes caseros 6. Hacer potaje de garbanzos con bacalao y espinacas 7. Hacer crumbl cookies 8. Hacer té matcha 9. Yogur casero 10. Hacer chocolate de Dubái ⁉️Por qué… 1. Se ha ido la luz 2. Israel ataca a Irán 3. Los Papas cambian de nombre 4. La Feria de Abril es en mayo 5. Han subido tanto los huevos 6. No hay luz en el espacio 7. Trump sube los aranceles 8. Me suenan las tripas 9. La sandía es símbolo de Palestina 10. Se pegan los bostezos ‍ Qué significa… 1. Edadismo 2. Queer 3. PH 4. Dana 5. Woke 6. Berghain 7. Nuda propiedad 8. FOMO 9. PEC 10. La hora espejo Que é mellor… 1. Diésel o gasolina 2. Gemini o ChatGPT 3. Mantequilla o margarina 4. Para la resaca 5. Declaración conjunta o individual 6. Amortizar plazo o cuota 7. Comprar un coche o renting 8. Desayunar antes o después de entrenar 9. Retinol o Retinal 10. Creatina o proteína Máis Información ACTUAL COMUNICACIÓN Amodiño: ✔️Páxina Web: https://actualizadoscomunicacion.com/ ✔️Facebook: https://www.facebook.com/actualizadoscomunicacion ✔️Twitter: https://twitter.com/actualizadoscom ✔️Instagram: https://www.instagram.com/actualizados_comunicacion/ ️"SUSCRÍBETE" ao podcast. MÁIS ENTREVISTAS: https://www.ivoox.com/podcast-salta-da-cama_sq_f1323089_1.html Máis Información e outros contidos: ✔️Facebook: https://www.facebook.com/PabloChichas ✔️Twitter: https://twitter.com/pablochichas ✔️Instagram: https://www.instagram.com/pablochichas/ ✔️ TikTok: https://www.tiktok.com/@pablochichas

Can smarter strategies to tame retinal fluid fluctuations actually improve long-term vision? In episode 3 of this miniseries, host Jay Sridhar, MD, and panelists Durga Borkar, MD, MMCi, and Christina Weng, MD, MBA, examine the data linking sustained delivery of therapy, reductions in retinal thickness changes, and positive long-term vision outcomes. After the break, the trio looks ahead to sustained TKI therapy via EYP-1901 (Duravyu, EyePoint Pharmaceuticals) by examining data from the DAVIO-2 study. Drs. Sridhar, Borkar, and Weng are paid consultants of EyePoint Pharmaceuticals; however, the statements made are the opinions of Drs. Sridhar, Borkar, and Weng for educational purposes only; their statements are not intended as medical advice or the opinion of EyePoint.

In this first episode of a 3-part roundtable series, moderator Jay Sridhar, MD, speaks with David Sarraf, MD, and Danny Mammo, MD, about retinal fluid fluctuation as a modifiable driver of outcomes in neovascular AMD and DME. The panel defines fluctuation across compartments, examines practical barriers to longitudinal OCT tracking, and assesses the undertreatment gap in real-world practice.  Drs. Sridhar, Mammo, and Sarraf are paid consultants of EyePoint Pharmaceuticals; however, the statements made are the opinions of Drs. Sridhar, Mammo, and Sarraf for educational purposes only; their statements are not intended as medical advice or the opinion of EyePoint.

Do retinal fluid fluctuations quietly erode long-term vision? In episode 2 of a 3-part roundtable series, moderator Jay Sridhar, MD joins guests Maggie Runner, MD, and Veeral Sheth, MD, MBA, to translate key data into clinic-ready tactics. They unpack how volatility—not just volume—of fluid correlates with outcomes, which fluid compartments matter most, and why durability reduces “yo-yo” anatomy. Drs. Sridhar, Runner, and Sheth are paid consultants of EyePoint Pharmaceuticals; however, the statements made are the opinions of Drs. Sridhar, Runner, and Sheth for educational purposes only; their statements are not intended as medical advice or the opinion of EyePoint.

In this episode, we review the high-yield topic of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Retinal Vein Occlusion⁠⁠⁠⁠ from the Ophthalmology section at ⁠⁠⁠⁠Medbullets.com⁠⁠⁠⁠⁠⁠Follow⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Medbullets⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets

The #1 Biggest Thing You Can Do for Your Health: Lose Weight — BUT Maintain Muscle. Dr. Lange explains why so many people lose weight rapidly and then end up with loose skin, wrinkles, and muscle loss. He emphasizes a simple but powerful concept: "Lose weight and build muscle at the same time". Muscle fills loose skin. Muscle boosts metabolism. Muscle preserves youth. Whether you’re losing weight naturally or through weight-loss medications, both doctors stress: You MUST Consume Enough Protein Daily to prevent muscle loss and maintain a healthy metabolism. Myostatin — The “Muscle Brake” That Increases with Age Dr. Lange and Dr. Summerton break down myostatin, the protein responsible for limiting muscle growth and accelerating age-related muscle decline. They discuss the clinically validated nutrients in Fortifeye Fit Pro® that help reduce myostatin activity: Creapure® Creatine Grass-Fed Whey Isolate Grass-Fed Collagen myHMB® (β-hydroxy β-methylbutyrate) Vitamin D3 Betaine Anhydrous And other muscle-support nutrients The doctors explain how stacking these ingredients helps you build lean muscle, lose fat, support strength, and minimize loose skin during weight loss. Fortifeye Next Gen Vitamin C — TRUE 8-Hour Sustained Release The show also introduces Fortifeye Next Gen Vitamin C, the only vitamin C using micro-beadlet sustained-release technology backed by clinical studies showing 8 hours of absorption. This advanced delivery helps: Immune support Skin and collagen health Reduced oxidative stress Fortifeye Next Gen Curcumin (Curcugen®) Dr. Summerton highlights Curcugen®, the only food-grade oleoresin curcumin that is clinically supported and highly absorbable for: Inflammation Joint health Gut and brain wellness Whole-body recovery rTG Omega-3 for Eye & Body Health Dr. Summerton also explains why she recommends rTG (re-esterified triglyceride) Omega-3 fish oil, especially for: Dry eye support Inflammation reduction Retinal and macular health She shares simple at-home tips for viral conjunctivitis as well. both doctors discuss using Lumenis Opti Light IPl for styes( chalazions and hordeolums) oftent times as first line of treatment vs oral antibiotics and surgical intervention. Opti light ipl treatment works well for chalazions and hordeolums. Live Call-In Questions Drive the Show As always, today’s program was packed with live questions from listeners—directing discussions on: Weight loss Muscle building Nutrition Eye health Viral conjunctivitis Supplement for Overall wellness A Packed Show with Actionable Takeaways From muscle preservation to omega-3 for dry eye, from sustained-release vitamin C to myostatin-blocking nutrition, this episode is full of practical science listeners can use immediately. #AskTheDr #DrMichaelLange #DrSusanSummerton #WeightLossTips #BuildMuscle #LoseWeightBuildMuscle #Myostatin #MyostatinBlocker #FortifeyeVitamins #FortifeyeFitPro #Creatine #Creapure #myHMB #CollagenProtein #WheyProtein #VitaminD #SustainedReleaseVitaminC #MicroBeadlet #Curcugen #Curcumin #Omega3 #rTGOmega3 #DryEye #EyeHealth #ViralConjunctivitis #HealthyLifestyle #AntiAging #MuscleHealth #GLP1WeightLoss #ProteinForWeightLoss #LooseSkin #WeightLossJourney #MuscleBuilding #FitnessOver50 #HealthyAging #NutritionScience #EyeCare #Fortifeye #lumenisoptilight #optilight #iplfordryeyeSupport the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

Please visit answersincme.com/UPU860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in managing patients with retinal vein occlusion (RVO) discusses the use of longer-acting anti-VEGF treatments for treating RVO. Upon completion of this activity, participants should be better able to: Explain the rationale for exploring longer-acting anti-VEGF treatment for patients with retinal vein occlusion (RVO); Differentiate the clinical profiles of available and emerging anti-VEGF treatments for macular edema following RVO, based on the latest evidence; and Propose optimized, patient-centered treatment plans for the multidisciplinary management of patients with RVO.

We love to hear from our listeners. Send us a message.In episode 116 of Cell & Gene: The Podcast, Host Erin Harris talks to Dr. Arun Upadhyay, Chief Scientific officer, Head of Research and Development at Ocugen to discuss how the company's modifier gene therapy platform is redefining treatment possibilities for inherited retinal diseases such as retinitis pigmentosa, Stargardt disease, and geographic atrophy. Dr. Upadhyay explains how Ocugen's gene-agnostic approach differs from traditional single-gene therapies by targeting shared disease pathways to preserve photoreceptors and slow vision loss across diverse genetic mutations. He also shares key lessons learned from advancing OCU400, the first modifier gene therapy to receive a broad FDA indication for retinitis pigmentosa, including challenges in clinical trial design, endpoint selection, and manufacturing scalability.Subscribe to the podcast!Apple | Spotify | YouTube Visit my website: Cell & Gene Connect with me on LinkedIn

Veonet Ireland has announced the introduction of DR.NOON AI Software by HeartEye Diagnostics - an AI-powered retinal screening system capable of detecting early signs of cardiovascular and diabetic vascular risk from a single, non-invasive eye retinal scan. At a time of high waiting lists for ophthalmology and cardiology, at 53,000 and 45,000 patients respectfully, DR.NOON offers a powerful preventive tool that can identify risk before symptoms appear. Built on clinically validated deep learning algorithms, DR.NOON AI software analyses subtle vascular patterns in the retina to uncover early indications of systemic disease, including hypertension, atherosclerosis, and microvascular changes associated with diabetes. Retinal screening to detect eye disease It delivers instant, AI-driven reports that match the outperform traditional methods in five-year cardiovascular risk prediction. This will include actionable insights for patients, identifying key risk indicators with personalised recommendations for lifestyle modification and disease management. With World Diabetes Day approaching on 14 November, the timing could not be more relevant. Diabetes remains a leading cause of vision loss among working-age adults, yet early detection can prevent over 90% of diabetes-related blindness, as it enables faster referral, timely treatment, and improved long-term outcomes for patients. Regular visits to your optometrist and enrolling in the Diabetic Retinal Screening Programme are as important as attending your diabetic clinic appointments. This is due to the increased risk of glaucoma, cataract and diabetic eye disease as a result of a diabetes diagnosis. "Diabetes, heart disease and vision loss are deeply interconnected, yet often diagnosed too late," explains Dr. Farah Ibrahim, Consultant Ophthalmologist at Veonet Ireland. "DR.NOON AI software changes that landscape - predicting cardiovascular risk for patients through a simple eye scan. This is preventive care in action: faster insights, earlier intervention, and ultimately, fewer patients joining already overstretched waiting lists." To mark its Irish debut, DR.NOON will be showcased at Veonet Ireland's upcoming CPD-accredited event, The Future of Vision: Emerging Advancements in Diabetic Eye Disease, taking place in Cork this Thursday, 13 November. The session will bring together optometrists, nurses, pharmacists and ophthalmic technicians to explore developments in diabetes eye management & experience how AI-driven innovation can reshape multidisciplinary diabetic eye care. You can learn more about the event, and reserve your spot in person or online, here. About Veonet Ireland Part of Veonet, Europe's leading ophthalmology group, Veonet Ireland is dedicated to delivering world-class, affordable, and accessible specialist eye care across Ireland. Founded by renowned ophthalmologists who recognised the value of sharing expertise, networking, and best practices, Veonet continues to advance the quality of ophthalmic care for patients across Europe. Veonet Ireland provides a supportive and positive environment where specialists and staff can grow both personally and professionally. Being a clinically led organisation, it empowers ophthalmologists to shape services and procedures in line with the highest clinical standards. See more breaking stories here. More about Irish Tech News Irish Tech News are Ireland's No. 1 Online Tech Publication and often Ireland's No.1 Tech Podcast too. You can find hundreds of fantastic previous episodes and subscribe using whatever platform you like via our Anchor.fm page here: https://anchor.fm/irish-tech-news If you'd like to be featured in an upcoming Podcast email us at Simon@IrishTechNews.ie now to discuss. Irish Tech News have a range of services available to help promote your business. Why not drop us a line at Info@IrishTechNews.ie now to find out more about how we can help you reach our audience. You can also find and follow us on Twitter, Linke...

Please visit answersincme.com/SYV860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, two experts in retinal vein occlusion (RVO) discuss diagnosis and anti-VEGF treatment of the condition. Upon completion of this activity, participants should be better able to: Explain the rationale for exploring longer-acting anti-VEGF treatment for patients with RVO; Recognize the importance of early diagnosis to address the burden of RVO; and Propose optimized, patient-centered treatment plans for the multidisciplinary management of patients with RVO.

Drs. Kat Talcott and Sarwar Zahid join to discuss the December 2025 edition of Retinal Physician, including an overview of TKIs for retinal disease, the fluorinated gas and sustainability question, best practices for research clinical trial sites, and fellowship selection advice.

A groundbreaking retinal implant, PRIMA, is restoring central vision in patients with geographic atrophy (GA), an advanced form of macular degeneration that blinds roughly 1 million Americans. Unlike drugs that slow progression, this wireless neurostimulation system captures real-world images, projects them onto a subretinal chip, and electrically stimulates surviving retinal cells to mimic natural sight. Are we nearing a paradigm shift in how we treat vision loss?

In this week's Outspoken Review I'm reminiscing about the most embarrassing Bonfire Night of my life and why I thought it would cost me a very new relationship.I've also got some stunning beauty products to tell you about. There's the most INCREDIBLE lip oil with a perfect berry tint, the shower oil of dreams, the yummiest of fragrances and the best hair repair mask in the business.Enjoy xx

This episode is a reproduction of another Retina-Focused EyeNovation webinar series and a result of a special collaboration between the Canadian Retina Society and the Canadian Ophthalmological Society. Dr. Ioannis Dimopoulos of the University of Ottawa provides a comprehensive overview of Inherited Retinal Disorders, with a specific focus on various gene therapy approaches. He details the outcomes of his involvement in treatment approaches for Choroideremia. Dr. Bernard Hurley of the University of Ottawa moderates this webinar. 

Vidcast:  https://www.instagram.com/p/DQdpWA_kS0y/Age-Related Macular degeneration is the leading cause of adult blindness, but Stanford University research ophthalmologists have developed an electronic retinal implant that promises to restore sight to millions.  Their device, nicknamed PRIMA standing for photovoltaic retina implant microarray, includes a subretinal wireless implant and wearable video camera.  The camera, mounted on an eyeglass frame, detects an image.  That image is converted by a pocket processor into infrared laser light signals that are directed through the lens of the eye to the implant under the retina.  The implant, in turn, creates the neural electrical  signals that restore sight. The implant is entirely light-powered and requires no external power supply.This PRIMA system underwent a multisite, primary clinical trial at Stanford, the University of Pittsburgh, and Germany's University of Bonn.  A remarkable 27 of 32 implanted patients, 84%, regained the ability to read books, labels, and even street signs.  Some could even correctly make out some of the smallest lines on a standard eye chart.  The vision is black and white.Further refinement of the PRIMA chip is underway that promises a higher resolution and a refined grayscale.  No word yet as to whether this system will restore full color vision, but bioengineering ingenuity might just achieve that result…..someday soon.https://www.sciencedaily.com/releases/2025/10/251022023118.htm#google_vignettehttps://www.nejm.org/doi/10.1056/NEJMoa2501396#blindness #maculardegeneration #amd #prima #retinalimplant

Interview with Noemi Lois, MD, PhD, author of Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy. Hosted by Neil Bressler, MD. Related Content: Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy

Interview with Noemi Lois, MD, PhD, author of Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy. Hosted by Neil Bressler, MD. An earlier posted version of this podcast may not have stated clearly enough that in areas with loss of perfusion and loss of sensitivity at baseline which remained non-perfused during the follow up, the sensitivity deficit declined over time. This has been corrected in the podcast. Related Content: Retinal Sensitivity and Retinal Perfusion in Diabetic Retinopathy

In this episode, we are joined by Drs. Thellea Leveque and Steven Yeh to discuss the myriad of considerations while managing retinal vasculitis.The discussants report no relevant financial disclosures.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/AFV865. CME/NCPD/AAPA/IPCE credit will be available until October 22, 2026.Enhancing Diagnosis and Management of Retinal Diseases in Urgent Care In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis program is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.Disclosure information is available at the beginning of the video presentation.

Drs. Marianeli Rodriguez and Kat Talcott join to discuss the October 2025 edition of Retinal Physician, including inherited retinal disease treatment pipeline, gene therapy, and systemic therapy for sickle cell disease and retinopathy.

Today's episode is all about visual thinking. We will explore vivid mental imagery and sensory processing. We will cover why Autistic individuals process detailed "pictures and movies" in the mind, exemplified by an anecdote of visualizing oak tree bark with tactile detail. Sensory challenges are highlighted, with a Bee Movie analogy illustrating the intense, efficient visual input. The Autistic sensory journey is described as fast but rocky, contrasting with non-autistic processing. Hyperconnectivity in visual pathways amplifies detail-oriented cognition, often leading to sensory overload.The episode explains how retinal ganglion cells and visual cortex hyperactivity enhance imagery in Autism. Kanner and Asperger's observations underscore visual memory strengths and technical interests, like pattern recognition. Increased mini-column density and reduced inhibition boost local processing but risk overload. Temple Grandin's insights show visual thinking's strengths in tasks like designing animal pathways, though social tasks challenge due to weaker prefrontal connectivity. The Autistic brain's wiring is framed as a unique strength, fostering intense, detailed cognitionTemple Grandin https://www.templegrandin.com/templegrandinbooks.htmlSensory Processing part 1 https://youtu.be/HTnFm8nY4oY?si=4Xso_tI_hMwhY_SXSensory Processing part 2 https://youtu.be/n31gyLb4ddM?si=CouaBhiVm8KixtG-Supplementing Relationships part 1 https://youtu.be/lglEGQ7pSlc?si=ncpla784LxOyUcQcSupplementing Relationships part 2 https://youtu.be/W8E2B7Qu4mg?si=UJE850SwvPmtOmEkDaylight Computer Companyuse "autism" for $50 off athttps://buy.daylightcomputer.com/autismChroma Light Devicesuse "autism" for 10% discount athttps://getchroma.co/?ref=autism00:00 Introduction to Visual Thinking02:00 Anecdote: Oak Tree Visualization; tree bark, tactile05:50 Sensory Processing Challenges; overload, information rate, avoidance09:40 Anecdote: Bee Movie Analogy; synchronized, intense, fast13:30 Autistic Sensory Rates/Speeds17:20 Eye Biology and Neural Relays; Retinal ganglion, SHANK3; Building Models details-to-general21:10 Magnocellular vs. Parvocellular Pathways; Motion, color, glutamate, GABA signaling25:00 Visual Cortex Hyperactivity; V1-V4, fMRI, synaptic pruning, details28:50 Mini-Columns and Sensory Overload; Neural units, inhibition, dense connections32:40 Kanner and Asperger Insights; Social isolation, technical interests, patterns38:39 Daylight Computer Company (and Daylight KIDS !), use "autism" for $50 discount40:54 Chroma Light Devices, use "autism" for 10% discount44:07 Reviews/Ratings & Contact InfoX: https://x.com/rps47586YT: https://www.youtube.com/channel/UCGxEzLKXkjppo3nqmpXpzuAemail: info.fromthespectrum@gmail.com

Drs. Akshay Thomas and Sarwar Zahid join to discuss the September 2025 edition of Retinal Physician, including port delivery system thoughts, AI for ROP, and suprachoroidal injections.

Join us for a first-look launch exclusive on Skin Anarchy as Dr. Ekta sits down with Keith O'Brien, the CEO of Hydrinity Accelerated Skin Science, to explore how regenerative medicine is transforming skincare. With a background in wound care, spine surgery, and oncology, Keith has applied the principles of rapid healing, pH balance, and inflammation control to aesthetics, creating products designed to repair, regenerate, and restore the skin.Hydrinity just launched their NEW RetaXome™ Daily Retinal Hydrator which is a proprietary, next-generation retinal-infused exosome that sets the new gold standard in regenerative retinoid therapy, offering high-dose, targeted delivery deep into the dermis — where it matters most.Hydrinity goes beyond facial care, addressing the unique needs of the body with formulas like the Encore Body Hydrator, which penetrates deeply with low molecular weight hyaluronic acid and high-dose antioxidants like Kakadu plum–derived vitamin C. Each product is designed with regenerative principles in mind: balancing pH, reducing inflammation, and supporting the skin's natural repair mechanisms.Science drives efficacy, but luxury isn't forgotten. Hydrinity formulations are clean, free from unnecessary dyes and fragrances, and crafted to feel as good as they perform.For Keith, consistency is key, and Hydrinity bridges the gap between biotech innovation and everyday beauty rituals. This episode offers a sneak peek into the future of skincare—where healing, science, and luxury intersect. Tune in to hear Keith O'Brien share the story behind Hydrinity, the science driving their formulations, and how regenerative medicine is reshaping both face and body care.To learn more about Hydrinity, visit their website and social mediaCHAPTERS:(0:02) Introduction & Guest Welcome(1:07) Hydrinity Origins & Wound Care Background(3:06) Expanding from Facial to Body Care(7:30) Scientific Principles: pH, Inflammation & Regenerative Medicine(11:20) Luxury Meets Science: Form, Function & Sensory Experience(16:11) Protocols, Estheticians & Evidence-Based Practice(19:01) Daily Habits & Importance of Body Skincare(21:18) New Product Launch: Hydrinity Retinol & Innovation(24:20) Retinol Therapy: Results, Stability & Gold StandardPlease fill out this survey to give us feedback on the show!Don't forget to subscribe to Skin Anarchy on Apple Podcasts, Spotify, or your preferred platform.Reach out to us through email with any questions.Sign up for our newsletter!Shop all our episodes and products mentioned through our ShopMy Shelf! Hosted on Acast. See acast.com/privacy for more information.

Eyepoint CFO George Elston provides insights on the evolving space of retinal disease treatment, focusing on capital allocation, medical innovation, industry engagement and financial prudence.

We discuss the current state of the Good Days charitable foundation with Dr. Michael Lai, MD. PhD, Retina Group of Washington, Assistant Clinical Professor, Georgetown University School of Medicine

Claudia Muehlenweg helps people naturally improve their vision and ditch their glasses for good. She also explores how unresolved emotions can affect eyesight and healing.New episodes of Welcome to Wellness released every Friday!Not listening on Spotify? Show notes at: https://www.ashleydeeley.com/w2w/claudiaeyehealthEpisode brought to you by: ⁠⁠⁠⁠⁠⁠⁠⁠⁠ARAZA Beauty⁠Episode brought to you by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ VieLight⁠⁠⁠ - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Code: DEELEY10Episode brought to you by:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Dry Farm Wines⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ 07:36: Understanding Vision: The Role of Stress and Mindset11:21: Nutrition for Eye Health: The Power of Food12:55: The Importance of Eye Exams and Technology16:22: Surgery vs. Natural Vision Improvement22:43: Strengthening Vision Post-Surgery24:22: Practical Tips for Better Vision30:19: What Harms Our Eyes: Bad Habits and Practices31:17: Anxiety is related to myopia31:35: Anger is connected to farsightedness 31:58: Staring is awful for your eyes (make sure to blink!)32:32: The Impact of Blue Light on Vision36:39: Emotional Connections to Vision Problems43:07: Exploring Common Eye Diseases48:59: Cataract Surgery: Insights and Considerations51:36: Addressing Stargardt's Disease and Other Retinal Issues56:03: Encouraging Healthy Vision in Children57:06Aging and Vision: What You Need to KnowWhere to find Claudia:WebsiteLinkedInWhere to find Ashley Deeley:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Website⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠hello@ashleydeeley.com

Drs. Safa Rahmani and Sarwar Zahid join to discuss the July 2025 Retinal Physician focusing on surgical cases and pearls. Relevant Financial Disclosures: None

Drs. Armstrong and Patel discuss current and emerging therapies for diabetes-related macular edema and wet age-related macular degeneration including anti-VEGF agents, the need for durability and reduced treatment burden, alternative delivery strategies, novel molecules, and gene-therapy.

Drs. Modi and Dedania discuss GLP-1 receptor agonists and the retinal patient, including how GLP-1 receptor agonists work, benefits and risks in patients with retinal disease, and data from retrospective studies.

Drs. Durga Borkar and Yashaswini Singh join host Dr. Jay Sridhar to discuss their recent publication regarding private equity (PE) acquisition and access to retinal detachment surgery. According to the study, physicians in PE-acquired practices decreased their number of retinal detachment repairs by nearly 20% after acquisition, potentially negatively impacting access to care and patient outcomes. Discussed in today's podcast: Singh Y, Cardenas GB, Torabzadeh H, Whaley CM, Borkar D. Private Equity-Owned Physician Practices Decreased Access To Retinal Detachment Surgery, 2014-22. Health Affairs. 2025 May;44(5):589-596. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Drs. Akshay Thomas and Sarwar Zahid join for a journal club podcast discussion of three recent high-impact articles:Visual Fields in Diabetic Retinopathy (https://www.ophthalmologyretina.org/article/S2468-6530(25)00208-8/abstract)Gender Differences in Case Volume (https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2833393)Private Equity Practices and Retinal Detachment Volume (https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.2024.01204?journalCode=hlthaff)Relevant Financial Disclosures: NoneYou can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi

Today, we are joined by the esteemed Dr. Jay Chhablani, a distinguished professor of ophthalmology and vitreoretinal surgeon at the Department of Ophthalmology, University of Pittsburgh. As the Director of Clinical Research at the UPMC Vision Institute, Dr. Chhablani stands at the forefront of cutting-edge advancements in eye care. Embark on a fascinating exploration as Dr. Chhablani, a retina specialist and surgeon, shares his wealth of knowledge on retinal diseases, ranging from bothersome floaters to age-related macular degeneration. Delve into the intricacies of ophthalmic surgeries, including the delicate art of retinal detachment repair. Press play to discover: The origins and prevention of eye floaters, along with effective treatment approaches. Conditions warranting surgical intervention for floaters. Navigating through complications associated with common ophthalmic surgeries and procedures. Distinguishing between the two primary forms of macular degeneration. The mechanics of novel drug therapies in slowing the progression of retinal diseases. Eager to learn more? Tune in and explore more at Jay Chhablani, MD | Department of Ophthalmology | University of Pittsburgh. Episode also available on Apple Podcasts: apple.co/30PvU9C